[1] |
Chinese Antituberculosis Association, Schools and Children Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis .
Expert consensus of clinical application of the recombinant Mycobacterium tuberculosis fusion protein (EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 761-768.
|
[2] |
YANG Lei, WEI Fen, ZHANG Kai, QIU Jing-jing, WANG Ying-ying, DU Wei-xin, LU Jin-biao, TAO Li-feng, PU Jiang.
Stability and efficacy study of recombinant Mycobacterium tuberculosis fusion protein (EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 799-806.
|
[3] |
ZHANG Kai, TAO Li-feng, WEI Fen, DU Wei-xin, QIU Jing-jing, CHEN Wei, CHEN Bao-wen, ZHU Yin-meng, CHENG Xing, SU Cheng, ZHONG Zai-xin, LU Jin-biao, PU Jiang.
Immune characteristics and preclinical animal safety studies of recombinant Mycobacterium tuberculosis fusion protein(EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 807-813.
|
[4] |
ZHANG Kai, SHEN Xiao-bing, TAO Li-feng, WEI Fen, CHEN Bao-wen, QIU Jing-jing, CHEN Wei, LU Jin-biao, ZHU Yin-meng, CHENG Xing, ZHONG Zai-xin, ZHAO Ai-Hua, PU Jiang.
Establishment of quality standards for recombinant Mycobacterium tuberculosis fusion protein
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 814-820.
|
[5] |
DU Wei-xin, WEI Fen, LU Jin-biao, ZHAO Ai-hua, PU Jiang, WANG Guo-zhi, XU Miao.
Preliminary establishment of national reference of the freeze-dried recombinant Mycobacterium tuberculosis allergen for the bulk potency evaluation
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 826-831.
|
[6] |
CHEN Feng-fang, MA Jun, HUANG Jin, YIN Hong-yun, SHA Wei, YANG Guang-hong, FENG Yong-hong.
Preliminary study on establishing the diagnostic model for smear negative tuberculosis and stage Ⅰ/Ⅱ sarcoidosis with hilar/mediastinal lymphadenopathy and positive T-SPOT.TB results
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 832-837.
|
[7] |
DUAN Li-ming, DING Chao, LIU Yu-gang, WEI Lin, GU Zhen-ning.
Application value of video-assisted thoracoscopic surgery in the treatment of chronic tuberculous empyema
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 850-853.
|
[8] |
QU Meng-jin, LIANG Zheng-min, WANG Yuan-zhi, ZHOU Xiang-mei.
Research progress of carbohydrate metabolism of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 874-879.
|
[9] |
SONG Yi-meng, LI Yuan-chun, HE Wen-cong, HE Ping, BAO Jing-jing, LIU Chun-fa, LIU Dong-xin, WANG Xin-yang, ZHAO Yan-lin, LI Yan-ming.
Cost analysis of fluorescence PCR probe melting curve technique for the detection of Mycobacterium tuberculosis resistance in China
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 712-717.
|
[10] |
ZHANG Jie, REN Yi-xuan, PAN Li-ping, ZHANG Zong-de.
Application of whole genome sequencing in research of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 737-740.
|
[11] |
LI Xin-na, SHEN Xin-xin, WANG Rui-bai, DUAN Su-xia, ZHANG Rui-qing, WANG Rui-huan, BAI Xue-ding, FAN Guo-hao, WANG Jin-rong, GAO Yuan, CHEN Zi-wei, MA Xue-jun.
Application value of probe-directed recombinase amplification assay in detecting MTB rpoB gene mutation
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 481-488.
|
[12] |
ZHANG Xing,WANG Feng-ming,LYU Xu-feng,HUA Tian-qi,ZHANG Xue-jun,JIANG Jing-yi,DING Chen-li,ZHU Wei,XIA Guo-dong,JI Jun-min,ZHAO Fei.
Analysis of influencing factors of Mycobacterium tuberculosis infection in HIV/AIDS patients
[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 360-365.
|
[13] |
ZHAO Jiao-jie,FU Lei,WANG Bin,ZHANG Lei,HU Ming-hao,LU Yu.
Establishment and application of pharmacodynamics and pharmacokinetics model in vitro
[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 372-379.
|
[14] |
YANG Han,YANG Jing-fen,WU Hao,CUI Xiao-li,DANG Li-yun.
Value of MicroDST test in detecting sensitivity of first-line anti-tuberculosis drugs
[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 380-384.
|
[15] |
CHEN Zhen-hua,LIU Bin-bin,CHEN Zhong-nan,TAN Yun-hong.
Establishment and preliminary evaluation of a diagnostic model for the new patients with pathogen-negative pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(3): 266-271.
|